Recently, the entry "Nguyen Tiu Mai’s Vinh Tan Album," submitted by China Southern Power Grid International (CSGI), stood out among nearly 2,000 entries from over 130 countries and regions worldwide and won the "Green Practices Award" at the Seventh Belt and Road Initiative Short Video Competition.
GUANGZHOU, China – The 138th China Import and Export Fair (Canton Fair) served as the launch platform for CVTE’s new robot product series, drawing notable interest from both domestic and international buyers. A key highlight was the first public showcase of the MAXHUB A3 Series Smart Flexible Manipulator.
SAN FRANCISCOand SUZHOU,China,Jan. 6,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qual
-Energy U Limited,Subsidiary of U Power,Forms Joint Venture to Deploy Battery Swapping Solutions-
SHANGHAI,Jan. 6,2025-- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power")
CLIFTON,N.J.,Jan. 7,2025-- DREO,the No. 1 fan and heater brand in the U.S. and proud recipient of theTIME Best Inventions 2024award for its groundbreaking kitchen innovation,is set to unveil a series
Enjoy Stunning Visuals with Yaber\'s Powerful K300s,L2 Plus,and T2 Series
LAS VEGAS,Jan. 7,2025-- Yaber,a pioneer in entertainment projectors,introduces three groundbreaking models: the ultra-short t
SHANGHAI and SAN DIEGO,Jan. 7,2025-- WuXi Biologics ("WuXi Bio") (2269. HK),a leading global Contract Research,Development,and Manufacturing Organization (CRDMO),today announced an agreement
CHANGZHOU,China,Jan. 7,2025-- Recently,the grid service pilot project of State Grid Changzhou Power Supply Company has demonstrated remarkable success. On January 7,with the proactive assistance of th
LAS VEGAS,Jan. 7,2025-- Huion,a leading brand in digital drawing technology,is debuting the Kamvas 16 (Gen 3) at CES 2025. This continues Huion\'s tradition of showcasing new products at CES. Kamvas
TOURS,France,Jan. 7,2025-- GORTEC,known as Head and Neck Radiation Oncology Group,today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab,Bristol Myers Squibb